News

Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development
QuantHealth raises $45M Series B to expand AI clinical trial simulation
read more
Biotech & Pharma Business,Drug Discovery & Development,Research & Development
Circio advances circular RNA gene therapy platform towards clinical development
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Jascayd approval expands treatment options for pulmonary fibrosis in Europe
read more
Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
National Health Council launches Detroit campaign to address kidney screening gap
read more
Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics
Enzene launches local biomanufacturing model to cut biologics manufacturing costs
read more
Genomics and sequencing,Manufacturing & Supply Chain,Research & Development
DNA Script and GE HealthCare awarded up to $26M for DNA bioproduction programme
read more
Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Vaximm reports encouraging VXM01 data in recurrent glioblastoma studies
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Aravax’s PVX108 wins FDA Fast Track designation for peanut allergy
read more
Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Medicus Pharma gets UAE approval to start genomics-guided endometriosis study
read more
Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain,Research & Development
First UK patient dosed in personalised lung cancer vaccine trial using Touchlight DNA technology
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Trixeo recommended for EU approval as asthma maintenance treatment
read more
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics
FDA approves Meitheal’s rapid-acting insulin biosimilar Garzulys
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Verdiva Bio starts Phase 1 trial of once-weekly oral amylin drug for obesity
read more
Biotech & Pharma Business,Manufacturing & Supply Chain,Research & Development
Clean Cells acquires Anaquant to expand mass spectrometry capabilities in biopharma quality control
read more
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
AB2 Bio receives $30 million as Nippon Shinyaku exercises US option for rare disease drug
read more
Digital & Data,Drug Discovery & Development,Research & Development
Causaly and Sage bring full-text scientific literature to AI drug discovery research
read more

QuantHealth raises $45M Series B to expand AI clinical trial simulation

Circio advances circular RNA gene therapy platform towards clinical development

Jascayd approval expands treatment options for pulmonary fibrosis in Europe

National Health Council launches Detroit campaign to address kidney screening gap

Enzene launches local biomanufacturing model to cut biologics manufacturing costs

DNA Script and GE HealthCare awarded up to $26M for DNA bioproduction programme

Vaximm reports encouraging VXM01 data in recurrent glioblastoma studies

Aravax’s PVX108 wins FDA Fast Track designation for peanut allergy

Medicus Pharma gets UAE approval to start genomics-guided endometriosis study

First UK patient dosed in personalised lung cancer vaccine trial using Touchlight DNA technology

Trixeo recommended for EU approval as asthma maintenance treatment

FDA approves Meitheal’s rapid-acting insulin biosimilar Garzulys

Verdiva Bio starts Phase 1 trial of once-weekly oral amylin drug for obesity

Clean Cells acquires Anaquant to expand mass spectrometry capabilities in biopharma quality control

AB2 Bio receives $30 million as Nippon Shinyaku exercises US option for rare disease drug

Causaly and Sage bring full-text scientific literature to AI drug discovery research

main menu

recent posts

ENA Respiratory begins Phase 2a dosing of nasal antiviral INNA-051

Circio raises NOK 200M (€18.6M) to advance in vivo CAR-T programme

AstraZeneca advances oral COPD drug into Phase 2b trial

get connected